- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06251128
Community Stroke Self-management Program
Community Stroke Self-management Program for Rural Dwelling African American Stroke Survivors
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mudasir Andrabi, Ph D
- Phone Number: 205) 348-9875
- Email: MANDRABI@UA.EDU
Study Contact Backup
- Name: Lin Chen, Ph D
- Email: clin@uabmc.edu
Study Locations
-
-
Alabama
-
Greensboro, Alabama, United States, 36744
- Recruiting
- The Hale County extension Office
-
Contact:
- Jovita Lewis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- History of Stroke
- High blood pressure condition
- African American
- Age 50 and above
Exclusion Criteria:
-Low cognition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-management
This group of participants will be given education and will be taught about overcoming the barriers to a healthy lifestyle and medication adherence.
No drugs or devices will be administered to the participants/
|
Our educational and behavioral program includes an educational component, problem-solving to overcome barriers to a healthy lifestyle, activities of daily living, and management of medications. No drugs or devices will be delivered to the participants
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Southampton Score Self Management Questionnaire
Time Frame: 3 months
|
Questionnaire; Each item on the Southampton Score Self-Management Questionnaire has a minimum score of 1 and a maximum score of 6. A higher score means better Self-management competency following a Stroke. The mean of the scores on this questionnaire will be computed for reporting overall scores on this measure. |
3 months
|
|
Hypertension Self-care Activity Level Effects
Time Frame: 3 months:
|
Questionnaire; Each item on self-care activity for management of Hypertension has a minimum score of 0 and a maximum score of 7. A higher score means a better Hypertension Self-care Activity Level. The mean of the scores on this questionnaire will be computed for reporting overall scores on this measure. |
3 months:
|
|
Hypertension Knowledge Level Scale Test
Time Frame: 3 months
|
Questionnaire; Each item on the Hypertension Knowledge Level Scale has a minimum score of 1 and a maximum score of 5. Higher scores on this scale mean a better Hypertension Knowledge Level. The mean of the scores on this questionnaire will be computed for reporting overall scores on this measure. |
3 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Mudasir Andrabi, Ph D, The University of Alabama
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-09-5982-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.